Formerly IMI International Medical Innovations. PreMD Inc., a predictive medicine company, empowers patients and physicians alike with simple, non-invasive tests that detect early-stage cardiovascular disease and cancer. Our mission is to prevent life-threatening illnesses and promote long-term health and wellness.
This test non-invasively measures cholesterol in the skin tissues to assess risk of heart disease.

This minimally invasive, painless test for colorectal cancer, currently in development, has several advantages over FOBT.

 

12/10/08

PreMD Files Provisional Patent Application Describing a New Method of Quanitifying Cancer BioMarkers

11/24/08

PreMD Inc. Enters Clinical Study with Cosmetics Conglomerate

11/13/08

PreMD Inc. Reports Third Quarter Results and Appoints New Chief Financial Officer

11/03/08

Listing Review initiated by the Toronto Stock Exchange

 

 

 

   

 

LungAlert™, currently in development, is non-invasive, inexpensive and may be more effective than other tests at detecting early-stage lung cancer.
This simple, non-invasive test, currently in development, has been shown to detect early-stage breast cancer.
Click here for detailed stock quote and chart information.
© Copyright 2007 All Rights Reserved